Ausgabe 3/2025
Inhalt (6 Artikel)
Why the Pharmaceutical Industry Needs Implementation Science for Sustainable Innovation
- Open Access
- Commentary
Anthony J. Messina
A Model for an Academia-Industry Collaboration for Pharmacovigilance and Pharmacoepidemiology
- Current Opinion
Alfred I. Neugut, Vinu George, Judith S. Jacobson, Michael D. Parkinson, Leslie E. Segall, Michelle Lebo, Charles C. Branas, Daniel E. Freedberg, Mirza I. Rahman
Importance of Health Economics and Outcomes Research in the Product Lifecycle
- Review Article
Amit Dang
Association Between Health-Related Quality of Life Measures and Survival Endpoints in Oncology Clinical Trials and in Clinical Decision Making: A Narrative Review
- Open Access
- Review Article
Anna Amela Valsecchi, Massimo Di Maio
Artificial Intelligence: Applications in Pharmacovigilance Signal Management
- Open Access
- Review Article
Jeffrey Warner, Anaclara Prada Jardim, Claudia Albera
Cost and Duration of Clinical Trials in Drug Development by Japanese Pharmaceutical Companies
- Open Access
- Original Research Article
Norihiro Okada, Yosuke Takahashi